ArticlePloS one2024
DRSegNet: A cutting-edge approach to Diabetic Retinopathy segmentation and classification using parameter-aware Nature-Inspired optimization.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An enhanced diabetic retinopathy detection approach using optimized deep learning technique.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is a prominent reason of blindness globally, which is a diagnostically challenging disease owing to the intricate process of its development and the human eye's complexity, which consists of nearly forty connected components like the retina, iris, optic nerve, and so on. This study proposes a novel approach to the identification of DR employing methods such as synthetic data generation, K- Means Clustering-Based Binary Grey Wolf Optimizer (KCBGWO), and Fully Convolutional Encoder-Decoder Networks (FCEDN). This is achieved using Generative Adversarial Networks (GANs) to generate high-quality synthetic data and transfer learning for accurate feature extraction and classification, integrating these with Extreme Learning Machines (ELM). The substantial evaluation plan we have provided on the IDRiD dataset gives exceptional outcomes, where our proposed model gives 99.87% accuracy and 99.33% sensitivity, while its specificity is 99. 78%. This is why the outcomes of the presented study can be viewed as promising in terms of the further development of the proposed approach for DR diagnosis, as well as in creating a new reference point within the framework of medical image analysis and providing more effective and timely treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.